We showed that exogenously expressed IRF5 unexpectedly antagonized the SS-inhibited CCAT1, and SS-induced miR-375-3p expressions (Figures 5A,B), and more importantly, neutralized SS-inhibited HCC cell growth (Figure 5C). Here, IRF5 is linked to hepatocellular carcinoma.